Home » Newsletters » BioWorld Science

BioWorld Science

June 16, 2022

View Archived Issues

rs41423247 SNP in NR3C1 gene predicts pneumonia complications in COVID-19

Novel vaccine candidates presented for Lassa fever

Merck & Co. patents orexin OX2 receptor agonists

Denali Therapeutics divulges new LRP3 inflammasome inhibitors

Dunad Therapeutics and collaborators present new GTPase KRAS inhibitors

Merck & Co. identifies new FXIa and/or KLKB1 inhibitors

U.S. researchers divulge new compounds for SARS-CoV-2 infection

Novel GLP-1 receptor agonist with improved oral bioavailability

Variants in the PABP-domain of PABPC1 associated with developmental delay

Genetic variants found in SLC35B2 gene tied to chondrodysplasia with hypomyelinating leukodystrophy

OliX subsidiary mCureX partners with Samyang and GC Pharma to advance mRNA vaccines

Vipergen enters derma drug discovery partnership with LEO Pharma

Lassen presents preclinical data on LASN-01 in preclinical models of skin fibrosis

Aqemia and Sanofi extend collaboration to use AI technology to optimize molecules to treat cancer

Nordic Bioscience and Roche strengthen biomarker collaboration

T cell-targeted vaccine for Coxiella burnetii infection shows promise in animal models

Blood vessel shape predicts what shape the heart is in

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.